Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Burrill Opens Registration for its 3rd Annual India Life Sciences MeetingApril 25, 2008
Burrill & Company, a global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media, today announced it has opened registration for the 3rd annual Burrill India Life Sciences Meeting to be held this year in San Diego in partnership with the San Diego life sciences association BIOCOM. The meeting, which dovetails with this year’s BIO 2008 International Convention in San Diego, will be held June 16 at the Omni San Diego Hotel.
India is a key player in the global life sciences industry and this year, the meeting features prominent speakers from the country's booming biopharma industry. At the event, biopharma executives with experience in cross-border dealing with India offer their insider's view to attendees. The meeting provides a unique opportunity to meet with top industry leaders focused on partnering and investing activities in India.
Since its launch, the meeting has become an important event for company executives, investors, service providers, and governmental officials interested in India's life sciences industry. This meeting serves as a powerful platform to connect the life science industries between India and the Western world.
Register online at the Burrill & Company website by going to http://www.burrillandco.com/bio/India08. The cost of the conference is $595. Register by May 7 to take advantage of the early bird rate of $495.
About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. The company's 60 person scientific and business team, supported by its 40-person Advisory Boards, the strategic and financial network of its limited partners, and the close relationships developed with numerous life sciences companies and management, provide Burrill with unparalleled access and insight.
Burrill is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports including: The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. In association with the California Healthcare Institute, Burrill publishes The Journal of Life Sciences, a bimonthly magazine and online at www.tjols.com. Burrill's flagship publication is its annual
State of the Industry report, the most recent 21st Edition being Biotech 2007: Life Sciences—A Global Transformation. The 22nd Edition is entitled Biotech 2008: Life Sciences—A 20/20 Vision to 2020, available 1Q 08. These publications provide the latest insight, intelligence and information on the life sciences industry.
Contact: Peter Winter, Editorial Director
Tel: 415-591-5474 firstname.lastname@example.org